OptimizeRx (OPRX) Return on Capital Employed (2016 - 2025)
OptimizeRx (OPRX) has disclosed Return on Capital Employed for 15 consecutive years, with 0.08% as the latest value for Q4 2025.
- Quarterly Return on Capital Employed rose 17.0% to 0.08% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.08% through Dec 2025, up 17.0% year-over-year, with the annual reading at 0.08% for FY2025, 16.0% up from the prior year.
- Return on Capital Employed hit 0.08% in Q4 2025 for OptimizeRx, up from 0.04% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.08% in Q4 2025 to a low of 0.19% in Q4 2023.
- Historically, Return on Capital Employed has averaged 0.07% across 5 years, with a median of 0.08% in 2025.
- Biggest five-year swings in Return on Capital Employed: dropped -10bps in 2022 and later rose 23bps in 2025.
- Year by year, Return on Capital Employed stood at 0.0% in 2021, then crashed by -3546bps to 0.1% in 2022, then plummeted by -100bps to 0.19% in 2023, then soared by 53bps to 0.09% in 2024, then surged by 184bps to 0.08% in 2025.
- Business Quant data shows Return on Capital Employed for OPRX at 0.08% in Q4 2025, 0.04% in Q3 2025, and 0.03% in Q2 2025.